Invesco’s PAVmed PAVM Stock Holding History

Invesco’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-54	Closed	-$32K	–	4115
2022 Q1	$32K	Sell	54 -1	-2%	-$743	﹤0.01%	3961
2021 Q4	$61K	Sell	55 -1	-2%	-$2.17K	﹤0.01%	3959
2021 Q3	$217K	Buy	56 +13	+30%	+$41K	﹤0.01%	3773
2021 Q2	$123K	Sell	43 -38	-47%	-$89.8K	﹤0.01%	3865
2021 Q1	$162K	Buy	81 +6	+8%	+$9.02K	﹤0.01%	3705
2020 Q4	$71K	Buy	+75	New	+$64.1K	﹤0.01%	3693

Other funds holding PAVM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco's PAVM Position: Q2 2022 in Review

Invesco sold out of PAVmed (PAVM) in Q2 2022, closing a stake of 54 shares — an estimated $32K sold.

Invesco first reported a position in PAVM in Q4 2020 and held it in 6 quarters. The position peaked at $217K in Q3 2021. 73 funds tracked by Wall St. Rank hold PAVM as of Q2 2022.

Invesco reported no remaining PAVmed position as of Q2 2022 after selling out during the quarter.
Invesco sold 54 PAVmed shares in Q2 2022, an estimated $32K.
Invesco first reported a position in PAVmed in Q4 2020 and held it in 6 quarters.
Invesco's PAVmed position peaked at $217K in Q3 2021.
73 funds tracked by Wall St. Rank held PAVmed as of Q2 2022.

Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.